Source: Eur Respir J 2014; 43: 1822-1823
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mura Marco. 6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis. Eur Respir J 2014; 43: 1822-1823

Member's Comments

No comment yet.

Related content which might interest you: 6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2014; 43: 1421-1429 Year: 2014 Change in 6-minute walk test can predict prognosis in idiopathic pulmonary fibrosis Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 The 6-min walk distance: change over time and value as a predictor of survival in severe COPD Source: Eur Respir J 2004; 23: 28-33 Year: 2004 Impact of pulmonary rehabilitation on six-minute walk distance in patients with very severe COPD Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention Year: 2010 The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension Source: Eur Respir Rev 2013; 22: 487-494 Year: 2013 Relationship between six-minute walk distance and chronic obstructive pulmonary disease assessment test Source: Annual Congress 2012 - Various issues in clinical physiology Year: 2012 FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change Source: Eur Respir J, 55 (5) 1902151; 10.1183/13993003.02151-2019 Year: 2020 The prognostic value of percent predicted six-minute walk distance in pulmonary arterial hypertension Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009 The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension Source: Eur Respir J 2010; 36: 1294-1301 Year: 2010 Correlation of composite physiologic index with 6-minute walk test variables in patients with idiopathic interstitial pneumonias Source: International Congress 2016 – Clinical exercise physiology in health and disease Year: 2016 6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID) Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Functional predictors of dyspnea, 6-min walking distance and HRCT score in idiopathic interstitial pneumonia Source: Annual Congress 2004 - Fibrosing lung diseases Year: 2004 Predictors for longitudinal change in 6-minute walk distance in COPD patients Source: Annual Congress 2012 - Outcomes and assessment methods in physiotherapy and rehabilitation Year: 2012 Role of exercise cardiac index to predict NYHA functional class, 6-minute walk test distance and survival in idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 The influence of selected sociodemographic parameters on the results of 6-minute walk test (6MWT) in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 243s Year: 2004 The 6-min walking distance: long-term follow up in patients with COPD Source: Eur Respir J 2007; 29: 535-540 Year: 2007 The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 96-103 Year: 2005 Relationship between six-minute walk test and resting lung function in patients with IPF Source: Eur Respir J 2003; 22: Suppl. 45, 45s Year: 2003 Influence of muscle mass and function and healthy status on six-minute walk distance in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 721s Year: 2005 Six-minute walk test correlates with hemodynamic severity in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 111s Year: 2004